Universe Pharmaceuticals INC financial data

Symbol
UPC on Nasdaq
Location
Ji'an, Jiangxi, China
Fiscal year end
30 September
Latest financial report
20-F - Q3 2025 - 29 Jan 2026

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 563,338 shares -98%
Common Stock, Shares, Outstanding 563,338 shares 1214%
Common Stock, Value, Issued $68,362 USD 0.58%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current $13,008,117 USD 0.79%
Inventory, Net $3,386,052 USD 18%
Assets, Current $53,603,675 USD 3.8%
Property, Plant and Equipment, Net $3,583,553 USD 0.43%
Intangible Assets, Net (Excluding Goodwill) $147,652 USD -8%
Assets $69,303,440 USD 2%
Accounts Payable, Current $1,669,785,000 USD 33875%
Contract with Customer, Liability, Current $40,708,000 USD
Liabilities, Current $13,173,930 USD
Liabilities $13,173,930,000 USD -41%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,813,522 USD
Retained Earnings (Accumulated Deficit) $13,843,623 USD
Stockholders' Equity Attributable to Parent $56,129,510 USD 23%
Liabilities and Equity $69,303,440 USD 2%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 2,000,000,000 shares 0%
Common Stock, Shares, Issued 563,338 shares 1214%
Common Stock, Par or Stated Value Per Share 0.0188 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $8,861,590 USD -32%
Deferred Tax Assets, Valuation Allowance $2,167,162,000 USD -1.4%
Property, Plant and Equipment, Gross $10,487,306 USD 2.5%
Preferred Stock, Shares Authorized 1,250,000 shares
Preferred Stock, Par or Stated Value Per Share 11.25 USD/shares